MIRA
MIRA PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.81
+7.11%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.03
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.03
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +55.3%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | — | -$0.03 | — | — |
| May 14, 2026 | — | -$0.03 | — | — |
| Mar 31, 2026 | -$0.04 | $0.03 | Beat 176.25% | — |
| Nov 13, 2025 | -$1.18 | -$1.18 | In line | — |
| Aug 14, 2025 | -$0.11 | -$0.09 | Beat 18.18% | — |
| May 14, 2025 | -$0.15 | -$0.11 | Beat 26.67% | — |
| Mar 28, 2025 | -$0.29 | -$0.15 | Beat 48.28% | $11.2M |
| Apr 1, 2024 | -$0.23 | -$0.39 | Miss -70.23% | — |
| Nov 13, 2023 | -$0.08 | -$0.26 | Miss -225.00% | — |
| Sep 15, 2023 | — | -$0.10 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026